DARWIN Digitale Dissertationen German Version Strich

FU Berlin
Digitale Dissertation

Francisco Ylera Dahmen :
Selection of high-affinity RNAs for the Alzheimer´s beta-amyloid
Selektion hochaffiner RNA-Moleküle gegen das Alzheimer beta-Amyloid

FU Logo


|Abstract| |Table of Contents| |More Information|

Abstract

Although the cause of the Alzheimer´s disease is still unknown, it is supposed to be closely related with the deposition of amyloid peptides in the brain of patients. The amyloid is thus a major target in the search for novel diagnostics and therapeutic approaches. This work employs RNA-technologies to develop new tools for the study of the Alzheimer´s disease. The in vitro selection enables the design of specific nucleic acids (aptamers) against almost any target molecule. The aptamers have similar properties as monoclonal antibodies, but several advantages. The chemical synthesis of these nucleic acids enables tailor-made modifications. By introduction of specific reporter groups these RNAs become suitable tools for analytical and diagnostic purposes. Since a change of the amyloid concentration has been reported in the blood of Alzheimer´s disease patients, the use of amyloid-specific aptamers for diagnosing the disease seems conceivable. Moreover, antibodies have been reported that prevent the aggregation of amyloid into senile plaques. This points towards a potential therapeutic application of the amyloid-specific aptamers.

High affinity RNA aptamers against the b A4(1-40) and a fragment b A4(1-16) were isolated from a combinatorial library of 1015 different molecules by using in vitro selection. For this purpose a DNA library containing 70 randomised nucleotides was chemically synthesised and transcribed into RNA. Affinic molecules were isolated after 8 rounds of selection and amplification. The apparent dissociation constants of these aptamers were 29-48 nM for the long peptide and 758 nM for the short b A4(1-16) fragment. The binding constants for the aptamers against the amyloid are within the range of the highest affinities so far described for peptide-specific aptamers.

This work introduces a new approach for the study and diagnosis of the Alzheimer´s disease. In future experiments, the efficacy of the aptamers needs to be tested. In addition, identifying the minimal binding motifs and enhancing the stability of the aptamers against RNase degradation are necessary steps to render these aptamers into reliable tools.


Table of Contents

Download the whole PhDthesis as a zip-tar file or as zip-File

For download in PDF format click the chapter title

Titel, Inhaltsverzeichnis

1 Einleitung

1.1 Morbus Alzheimer

1.2 RNA

1.3 In vitro-Selektion

1.4 Stabilisierung von RNA

1.5 Vergleich von Aptameren und Antikörpern

2 Aufgabenstellung

3 Methoden

3.1 Chemische Nukleinsäuresynthese

3.2 Aufreinigung von Nukleinsäuren

3.3 Molekularbiologische Methoden

3.4 Vorbereitung der Affinitätschromatographie

3.5 Mikrobiologische Methoden

3.6 Charakterisierung der Aptamere

4 Ergebnisse

4.1 Immobilisierung der Peptide

4.2 In vitro-Selektion

4.3 Charakterisierung der Aptamere

5 Diskussion

6 Zusammenfassung

7 Summary

8 Literaturverzeichnis

Anhang

A Geräte, Enzyme und Chemikalien

B Puffer und Medien

C Lebenslauf

D Eigene Publikationen


More Information:

Online available: http://www.diss.fu-berlin.de/1999/33/indexe.html
Language of PhDThesis: german
Keywords: selex, in vitro selection, aptamer, alzheimer´s disease, amyloid, RNA
DNB-Sachgruppe: 30 Chemie
Date of disputation: 29-Apr-99
PhDThesis from: Department Biologie, Chemie, Pharmazie, Freie Universität Berlin
First Referee: Prof. Dr. Volker A. Erdmann
Second Referee: Prof. Dr. Brigitte Wittmann-Liebold
Contact (Author): ylera@email.com
Contact (Advisor): erdmann@chemie.fu-berlin.de
Date created:09-Jun-99
Date available:16-Jun-99

 


|| DARWIN|| Digitale Dissertationen || Digitale Dissertationen : Autoren A-Z || Dissertation|| German Version|| FU Berlin|| Seitenanfang ||


Mail-Icon Fragen und Kommentare an:
darwin@inf.fu-berlin.de

© Freie Universität Berlin 1999